1
4
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38129 |
Leukotriene F4
LTF4 |
||
LTF4 is a cysteinyl-leukotriene produced in vitro, but not reported to date in vivo. It is formed by the incubation of LTE4 with γ-glutamyl transpeptidase and glutathione. LTF4 is a weak agonist in its ability to contract vascular smooth muscle. [1] The rank order of potency of the cysteinyl-leukotrienes to contract vascular smooth muscle is LTD4 > LTC4 > LTE4 >> LTF4. [1] [2] |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPJ-00513 |
LTF Protein, Human, Recombinant (His)
Lactoferroxin-A,Talalactoferrin,LTF,Lactotransferri... |
Human | HEK293 Cells |
Lactotransferrin is a member of the transferrin family that transfer iron to the cells and control the level of free iron in the blood and external secretions. Lactotransferrin is a secreted protein and contains two transferrin-like domains. Lactotransferrin can be cleaved into the following four chains: Kaliocin-1, Lactoferroxin-A, Lactoferroxin-B, and Lactoferroxin-C. Lactoferroxin A, Lactoferroxin B, and Lactoferroxin C have opioid antagonist activity. Lactoferroxin A shows preference for mu-... | |||
TMPY-02188 |
Lactoferrin/LTF Protein, Human, Recombinant (His)
HEL110,LF,HLF2,GIG12,lactotransferrin |
Human | HEK293 Cells |
Lactoferrin/LTF Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 77.5 kDa and the accession number is P02788. | |||
TMPY-02728 |
Lactoferrin/LTF Protein, Mouse, Recombinant (His)
MMS10R,Lf,Csp82,lactotransferrin,Ms10r |
Mouse | HEK293 Cells |
Lactoferrin/LTF Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 77.2 kDa and the accession number is AAH06904.1. | |||
TMPH-01540 |
Intelectin-1/ITLN1 Protein, Human, Recombinant (His & Myc)
|
Human | E. coli |
Lectin that specifically recognizes microbial carbohydrate chains in a calcium-dependent manner. Binds to microbial glycans that contain a terminal acyclic 1,2-diol moiety, including beta-linked D-galactofuranose (beta-Galf), D-phosphoglycerol-modified glycans, D-glycero-D-talo-oct-2-ulosonic acid (KO) and 3-deoxy-D-manno-oct-2-ulosonic acid (KDO). Binds to glycans from Gram-positive and Gram-negative bacteria, including K.pneumoniae, S.pneumoniae, Y.pestis, P.mirabilis and P.vulgaris. Does not ... |